Back to Search
Start Over
PanTher Therapeutics Presented Positive First-in-Human Data for PTM-101 in Pancreatic Cancer at AACR Annual Meeting
- Source :
- Plus Company Updates. April 9, 2024
- Publication Year :
- 2024
-
Abstract
- AUSTIN: PanTher Therapeutics (PanTher or the Company), a clinical-stage oncology company developing high-dose, long lasting, localized treatments for cancer, today presented positive data from a first-in-human study of PTM-101, a [...]
- Subjects :
- Medical research -- Conferences, meetings and seminars
Medicine, Experimental -- Conferences, meetings and seminars
Chemotherapy -- Conferences, meetings and seminars
Cancer -- Chemotherapy
Pancreatic cancer -- Conferences, meetings and seminars
General interest
News, opinion and commentary
Subjects
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Plus Company Updates
- Publication Type :
- News
- Accession number :
- edsgcl.792532665